Viridian Therapeutics VRDN
Last Price
52 Week Range
$9.90 - $34.04
Next Earnings Date
Feb 26 2026 (Estimate)
Next Earnings Date
Feb 26 2026 (Est.)
Last Price
VRDN Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Viridian Therapeutics, Inc. | 8-K | November 5, 2025 | |
Viridian Therapeutics, Inc. | 10-Q | November 5, 2025 | |
Viridian Therapeutics, Inc. | 8-K | October 23, 2025 | |
Viridian Therapeutics, Inc. | 8-K | October 21, 2025 | |
Viridian Therapeutics, Inc. | S3ASR | September 5, 2025 | |
Viridian Therapeutics, Inc. | 8-K | August 6, 2025 | |
Viridian Therapeutics, Inc. | 10-Q | August 6, 2025 | |
Viridian Therapeutics, Inc. | 8-K | July 30, 2025 | |
Viridian Therapeutics, Inc. | 8-K | June 24, 2025 | |
Viridian Therapeutics, Inc. | 8-K | May 20, 2025 | |
Viridian Therapeutics, Inc. | 10-Q | May 6, 2025 | |
Viridian Therapeutics, Inc. | 8-K | May 6, 2025 | |
Viridian Therapeutics, Inc. | DEF 14A | April 25, 2025 | |
Viridian Therapeutics, Inc. | DEFA14A | April 25, 2025 | |
Viridian Therapeutics, Inc. | ARS | April 25, 2025 | |
Viridian Therapeutics, Inc. | 8-K | April 7, 2025 | |
Viridian Therapeutics, Inc. | 8-K | March 10, 2025 | |
Viridian Therapeutics, Inc. | 8-K | March 4, 2025 | |
Viridian Therapeutics, Inc. | 10-K | March 3, 2025 | |
Viridian Therapeutics, Inc. | 8-K | February 27, 2025 | |
Viridian Therapeutics, Inc. | 8-K | January 10, 2025 | |
Viridian Therapeutics, Inc. | 8-K | December 16, 2024 | |
Viridian Therapeutics, Inc. | 10-Q | November 12, 2024 | |
Viridian Therapeutics, Inc. | 8-K | November 12, 2024 | |
Viridian Therapeutics, Inc. | 8-K | September 12, 2024 | |
Viridian Therapeutics, Inc. | 8-K | September 10, 2024 | |
Viridian Therapeutics, Inc. | 10-Q | August 8, 2024 | |
Viridian Therapeutics, Inc. | 8-K | August 8, 2024 | |
Viridian Therapeutics, Inc. | 8-K | July 15, 2024 | |
Viridian Therapeutics, Inc. | 8-K | June 20, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.